Back to Results
First PageMeta Content
Valeant Pharmaceuticals / Proxy statement / Mergers and acquisitions / J. Michael Pearson / Forward-looking statement / Schedule 13D / SEC filings / Business / Allergan


An Unrivaled Platform for Growth & Value Creation in Healthcare Valeant Pharmaceuticals International, Inc. + Allergan, Inc.
Add to Reading List

Document Date: 2014-04-28 13:34:06


Open Document

File Size: 1,29 MB

Share Result on Facebook

Company

Pershing Square Capital Management L.P. / First Call / Valeant Pharmaceuticals International Inc. / Healthcare Valeant Pharmaceuticals International Inc. / RBC Capital Markets / Allergan Inc. / Barclays / Speakers J. Michael Pearson / /

Country

United States / /

Currency

USD / /

Event

M&A / Dividend Issuance / /

IndustryTerm

healthcare / /

Organization

CSA / Securities and Exchange Commission / /

Person

Howard Schiller / J. Michael Pearson / Ari Kellen / /

Position

Executive Vice President and Chief Financial Officer / Governor / analyst / Chairman of the Board and Chief Executive Officer / Private / Executive Vice President and Company Group Chairman / /

PublishedMedium

Ophthalmology / /

URL

http /

SocialTag